The Board of Directors of Vijaya Diagnostic Centre Limited met on September 11, 2026, and approved the acquisition of the integrated diagnostic business undertaking of Arya Wellness Centre on a slump sale basis. The transaction is valued at a lump-sum cash consideration of ₹46.20 Crores, subject to customary working capital adjustments. The transaction is expected to be completed within 90 days, subject to regulatory approvals and customary closing conditions.

The acquired target is a B2C-focused integrated diagnostic business providing comprehensive pathology and radiology services based in Guwahati, Assam. It generated a turnover of ₹26.95 Crores in FY 2025-26, compared to ₹25.61 Crores in FY 2024-25 and ₹22.99 Crores in FY 2023-24. This strategic move aligns with Vijaya Diagnostic’s objective to establish its footprint in Assam and scale its business in North-East India. Upon closing, Vijaya Diagnostic will assume 100% operational control over the undertaking.

Vijaya Diagnostic Centre Limited is a major healthcare diagnostic chain in India providing B2C-driven radiology and pathology services. In 2025 and 2026, the company actively pursued regional expansion across South and East India, including setting up new hub facilities in Bengaluru and expanding its network footprint. The company maintains strong B2C revenue concentration and has earned accolades such as the Most Preferred Workplace 2026-2027 by Team Marksmen.

For the first quarter of FY 2026-27 (Q1 FY27 ended June 2026), Vijaya Diagnostic Centre reported consolidated revenue of ₹230.98 Crores, representing a 5.29% growth quarter-on-quarter (QoQ) compared to ₹219.38 Crores in Q4 FY26 and a 22.80% growth year-on-year (YoY) from ₹188.10 Crores in Q1 FY26. The consolidated net profit for Q1 FY27 reached ₹53.10 Crores, growing 10.63% QoQ from ₹48.00 Crores in Q4 FY26 and 38.51% YoY from ₹38.34 Crores in Q1 FY26. Prominent institutional investors holding stakes in the company include Fidelity Management & Research, Nippon Life India Mutual Fund, and Kotak Mutual Fund.